Sharemaestro Newsreel

West Pharmaceutical Services, Inc. $WST Position Reduced by Seilern Investment Management Ltd

Seilern Investment Management Ltd reduced its stake in West Pharmaceutical Services (NYSE:WST) by 38.8% in Q2 2026, selling 87,791 shares and retaining 138,230 shares worth $49.6 million. Despite this reduction, WST remains Seilern's 7th largest holding, and institutional investors collectively own 93.9% of the …

RMD Q2 Deep Dive: Margin Pressures Weigh Despite Product Momentum and Portfolio Shifts

RMD Q2 Deep Dive: Margin Pressures Weigh Despite Product Momentum and Portfolio Shifts Medical device company ResMed (NYSE:RMD) met Wall Street's revenue expectations in Q2 CY2026, with sales up 8.6% year on year to $1.46 billion. Its non-GAAP profit of $2.95 per share was …

Wall Street Zen Upgrades OraSure Technologies (NASDAQ:OSUR) to Hold

Wall Street Zen has upgraded OraSure Technologies (NASDAQ:OSUR) from a "sell" to a "hold" rating, while Weiss Ratings also improved its rating from "sell (e+)" to "sell (d-)". Despite this, analysts collectively rate the stock as "Reduce" with an average price target of $3.00. …

Bausch + Lomb Updates Board, Reaffirms 2026 Guidance

Bausch + Lomb Corporation announced changes to its board of directors, appointing four new members following a request from majority stakeholder Bausch Health Companies Inc. The company also reaffirmed its full-year 2026 guidance, which includes revenue projections between $5.440 billion and $5.540 billion, and …

Repligen (RGEN) Is Up 16.2% After Revenue Rises But Profitability Compresses In Q2 2026

In July 2026, Repligen Corporation reported second-quarter 2026 results showing revenue of US$204.13 million versus US$182.37 million a year earlier, while net income fell to US$5.01 million from US$14.87 million and diluted EPS from continuing operations decreased to US$0.09 from US$0.26. Over the six-month …

Teleflex Q2 Earnings Call Highlights

Teleflex reported Q2 revenue and adjusted earnings above expectations, driven by strong Vascular and Surgical business growth. However, the slower-than-anticipated integration of its Vascular Intervention acquisition impacted Interventional results. The company outlined plans for divestitures, debt reduction, and share repurchases, and updated its full-year …

Daxor Corp (DXR) Stock News Today

This article provides the latest stock news for Daxor Corp (DXR) from TradingKey. It shows the company's current stock price, market capitalization, P/E ratio, and highlights that more news and updates are expected soon. The page serves as a hub for financial information regarding …

ETFs Investing in West Pharmaceutical Services, Inc. Stocks

This article lists various Exchange Traded Funds (ETFs) that hold stocks of West Pharmaceutical Services, Inc. The ETFs are sorted by market value and include details such as weight, issuer, management style, expense ratio, assets under management (AUM), price, and 3-year NAV total return. …

Wall Street Zen Downgrades Nyxoah (NASDAQ:NYXH) to Sell

Wall Street Zen has downgraded Nyxoah (NASDAQ:NYXH) from "hold" to "sell," with the company's shares opening at $1.47, near their one-year low. This downgrade comes as Nyxoah missed its quarterly EPS estimates by $0.20, reporting a loss of $0.67 per share, although revenue slightly …

Join Class Action to Recover Losses from Baxter International, Inc. (BAX) - Contact Levi & Korsinsky Before December 15, 2025

Levi & Korsinsky, LLP has filed a class action securities lawsuit against Baxter International, Inc. (NYSE: BAX) on behalf of shareholders who suffered losses due to alleged securities fraud between February 23, 2022, and July 30, 2025. The lawsuit claims Baxter made false statements …

Will Envista’s Strong Q2 and Raised 2026 Guidance Change Envista Holdings' (NVST) Narrative

Envista Holdings Corporation recently reported Q2 2026 results showing higher sales of US$730.5 million and net income of US$53.7 million, with earnings per share from continuing operations rising to US$0.33. Alongside these results, Envista completed share repurchases totaling 12,458,894 shares for US$250 million, while …

How Investors Are Reacting To STAAR Surgical (STAA) Formalizing Warren Foust’s CEO Role And Leadership Structure

STAAR Surgical (STAA) recently formalized Warren Foust's role as President, CEO, and director, with Deborah Andrews becoming Executive Vice President and CFO, solidifying a leadership structure that was previously interim. This move is seen as reinforcing investor confidence by consolidating control under a leader …

Warby Parker Q2 Earnings Call Highlights

The Smart Glasses Gold Rush Is Leaving Old-School Eyewear Behind Warby Parker (NYSE:WRBY) reported second-quarter revenue of $235.5 million, up 9.8% from a year earlier, as retail sales growth, eye exam expansion and higher average order values helped offset continued softness in customer traffic …

Repligen (RGEN) Could Be 10% Below Fair Value On Mixed Q2 Earnings

Repligen (RGEN) recently reported mixed Q2 2026 earnings, showing higher revenue but lower net income and EPS year-over-year. Despite this, the stock has seen strong recent momentum, with a 90-day return of 41.4% and a 1-year return of 47.09%, positioning it about 10% below …

ResMed Inc Balances Astral Hit With Robust Core Growth

ResMed Inc. reported robust Q4 earnings with 9% revenue growth and 16% non-GAAP EPS increase, driven by strong performance in its core sleep-therapy business and expanding margins. Despite a significant setback from a $42 million provision and sales suspension due to a field-safety action …

Notable healthcare headlines for the week: Eli Lilly, Novo Nordisk, and Pfizer in focus

Wall Street’s major market averages ended higher on Friday after July's nonfarm payrolls surprised to the downside, showing an unexpected contraction in employment. The blue-chip Dow edged up 0.3%, the benchmark S&P 500 gained 0.62%, and the tech-focused Nasdaq Composite jumped 1.3%. The S&P …

Avantor, Inc. (AVTR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation

Bronstein, Gewirtz & Grossman, LLC is investigating potential claims against Avantor, Inc. (NYSE:AVTR) on behalf of shareholders who purchased securities prior to March 5, 2024, and continue to hold them. The investigation focuses on whether Avantor and its officers engaged in corporate wrongdoing. The …

Why Baxter (BAX) Is Up 5.3% After $500 Million Debt Tender And CFO Transition News

Earnings Week Ahead: SMCI, CSCO, JD, PLUG, and more

[Business Person Reviewing Quarterly Report During Meeting in Office Setting] The second full week of August features a diverse earnings slate spanning AI infrastructure, semiconductors, space technology, healthcare, financials, and consumer names, with Super Micro Computer (SMCI [https://seekingalpha.com/symbol/SMCI]), Nebius (NBIS [https://seekingalpha.com/symbol/NBIS]), Cisco Systems (CSCO …

Janus Henderson Group PLC Buys 21,094 Shares of Solventum Corporation $SOLV

Janus Henderson Group PLC significantly increased its stake in Solventum Corporation by 180.5% in the first quarter, now holding 32,780 shares valued at approximately $2.14 million. This move follows Solventum's strong Q2 performance, where it surpassed earnings and revenue expectations, and raised its fiscal …

Assenagon Asset Management S.A. Buys 457,938 Shares of The Cooper Companies, Inc. $COO

Assenagon Asset Management S.A. significantly increased its stake in The Cooper Companies (NASDAQ:COO) by 674.1% in the second quarter, purchasing 457,938 additional shares to own a total of 525,872 shares valued at $37.7 million. This move is part of a broader trend of institutional …

Becton Dickinson (BDX) Stock Still Looks Cheap After Its 19% Run

Becton Dickinson (BDX) has seen a 19.2% return over the past year, and despite this run, its stock appears undervalued by about 24.4% according to a Discounted Cash Flow (DCF) model, largely due to recent upward revisions in revenue and earnings guidance. While the …

Janus Henderson Group PLC Sells 82,283 Shares of STAAR Surgical Company $STAA

Versant Media Group, Inc. (VSNT) Stock Forecasts

Argus has lowered its target price for Versant Media Group Inc. (VSNT) to $38.00, assigning the company a "HOLD" investment rating. The report indicates subratings of Medium for Industry, Safety, and Financial Strength, and Low for Management, Growth, and Value. The current price of …

How Q2 Results and Alina GLP-1 Approvals At Stevanato Group (STVN) Have Changed Its Investment Story

Stevanato Group (STVN) recently reported mixed Q2 2026 results with increased sales but decreased net income and slightly narrowed full-year guidance. Simultaneously, European marketing authorizations for its Alina GLP-1 variable-dose pen injector platform highlight the company's growing presence in self-administered injectable therapies, offering tangible …

Avity Investment Management Inc. Sells 18,213 Shares of Becton, Dickinson and Company $BDX

Chemistry Wealth Management LLC Acquires 7,935 Shares of Becton, Dickinson and Company $BDX

Solventum (SOLV) Stock Fair Value Rises After Q2 And HIS Separation Plans

Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. Solventum's analyst fair value estimate has been revised from US$82.15 to US$93.15, a shift of about 13% in the updated framework. This adjustment …

Amundi Decreases Position in AptarGroup, Inc. $ATR

Amundi significantly reduced its stake in AptarGroup, Inc. (NYSE:ATR) by 70.9% in the first quarter, selling 19,646 shares and retaining 8,074 shares valued at approximately $1.02 million. Despite this, institutional investors still hold a substantial 88.52% of the company's stock. AptarGroup has seen insider …

OraSure Technologies Inc (OSUR) Earnings Forecast: Future EPS & Revenue Growth Estimates

EMBC|Embecta Corp|Price:4.420|Chg%:+0.920

ICU Medical (ICUI) Stock Gets Fair Value Boost After Analysts Lift Targets

ICU Medical (ICUI) has seen its analyst fair value increase from US$172.50 to US$191.50 due to positive analyst revisions and target hikes. Analysts cite improving margins, progress on free cash flow, and strong execution as reasons for their bullish outlook, with some firms raising …

Becton Dickinson (BDX) Stock Sees Modest Fair Value Lift After Mixed Analyst Views

Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. Becton Dickinson has seen its analyst fair value estimate move from US$181.23 to US$189.58, signaling a refreshed price target framework that investors are watching …

Bionano Genomics | 8-K: Current report

This article is a current report (8-K filing) from Bionano Genomics. It provides links to two separate documents for more details. The content explicitly states that it is for informational and educational purposes only and does not constitute investment advice.

Did Align’s Expanded 2026 Buyback and Board Refresh Just Shift Align Technology's (ALGN) Investment Narrative?

Align Technology recently reported Q2 2026 results, showing increased sales but softer Q3 guidance and outlining impacts from restructuring and legal charges. In conjunction with Elliott Investment Management, Align committed to new board members, a strategic review, and an expanded 2026 share repurchase plan …

ResMed Q4 Earnings Call Highlights